Cargando…
A Mixture Model for Estimating SARS-CoV-2 Seroprevalence in Chennai, India
Serological assays used to estimate the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) often rely on manufacturers’ cutoffs established on the basis of severe cases. We conducted a household-based serosurvey of 4,677 individuals in Chennai, India, from January to May 2021...
Autores principales: | Hitchings, Matt D T, Patel, Eshan U, Khan, Rifa, Srikrishnan, Aylur K, Anderson, Mark, Kumar, K S, Wesolowski, Amy P, Iqbal, Syed H, Rodgers, Mary A, Mehta, Shruti H, Cloherty, Gavin, Cummings, Derek A T, Solomon, Sunil S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472327/ https://www.ncbi.nlm.nih.gov/pubmed/37084085 http://dx.doi.org/10.1093/aje/kwad103 |
Ejemplares similares
-
The Hidden Burden of Dengue and Chikungunya in Chennai, India
por: Rodríguez-Barraquer, Isabel, et al.
Publicado: (2015) -
Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India
por: Cepeda, Javier A., et al.
Publicado: (2016) -
Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India
por: Solomon, Sunil S., et al.
Publicado: (2016) -
The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India
por: Solomon, Sunil S, et al.
Publicado: (2011) -
Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India
por: Mehta, Shruti H., et al.
Publicado: (2016)